Valeant Pharmaceuticals has signed an agreement to obtain certain assets from Atlantis Pharma, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71m. The transaction is expected ...
Tags: Valeant Pharmaceuticals, analgesics, anti-inflammatory therapeutic